Development of resistance and cross-resistance in vitro to erythromycin, carbomycin, spiramycin, oleandomycin and streptogramin.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000904:Antibiotics, Antitubercular; D004917:Erythromycin / Q000494:pharmacology*; D066298:In Vitro Techniques; D007933:Leucomycins / Q000494:pharmacology*; D008837:Micrococcus / Q000187:drug effects*; D009827:Oleandomycin; D015572:Spiramycin; D013211:Staphylococcus aureus; D025361:Streptogramins
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D007933:Leucomycins; D025361:Streptogramins; C059423:carbomycin; D004917:Erythromycin; D015572:Spiramycin; D009827:Oleandomycin
ANTIBIOTICS/effects; CARBOMYCIN/effects; ERYTHROMYCIN/effects; MICROCOCCUS PYOGENES/effect of drugs on